544 results about "Reducing bodies" patented technology

This invention relates the use of glucagon-like peptides such as GLP-1, a GLP-1 analog, or a GLP-1 derivative in methods and compositions for reducing body weight.

Improved methods and devices are provided for detecting and / or predicting the onset of an undesirable physiological event or neural state, such as an epileptic seizure, to facilitate rapid intervention with a treatment therapy such as neurostimulation or drug therapy. The methods and devices involve monitoring the patient's body temperature, preferably by an implanted temperature sensor, to detect a change in a body temperature parameter over a first time period. The temperature parameter change may comprise an increase or decrease in the patient's body temperature over a first time period, time rate of change of body temperature over a first time period, a moving average temperature over a first time period, an increase or decrease in body temperature exceeding a target temperature over a first time period, an elevated or reduced body temperature over first time period, or a temperature stability parameter over a first time period. The sampling period at which body temperature measurements are made may be changed manually or depending upon a sensed body parameter, including temperature. When a parameter change is detected that exceeds a threshold, neurostimulation therapy is delivered to a neural structure of the patient.

The present invention relates to compositions, such as bimatoprost, latanoprost and travoprost, and methods to reduce fat in the body of an individual, for example, by topical administration, injection, and / or implantation of such compositions.

Active cooling of a person, such as to induce mild / moderate hypothermia, is accomplished by transferring heat from the persons body. Heat transfer and patient comfort are aided by administration of an anti-shivering drug and an anti-emetic drug.

In a FinFET integrated circuit, the fins are formed with a reduced body thickness in the body area and then thickened in the S / D area outside the body to improve conductivity. The thickening is performed with epitaxial deposition while the lower portion of the gates are covered by a gate cover layer to prevent thickening of the gates at the fin level, which may short the gate to the S / D.

The present invention relates to a composition for treating obesity-related diseases comprising an insulinotropic peptide conjugate, more particularly, to a composition for treating obesity-related diseases comprising a conjugate prepared by covalently linking the insulinotropic peptide with a carrier substance via a non-peptidyl linker, and a method for treating obesity-related diseases by using the same. In particular, the composition for treating obesity-related diseases according to the present invention remarkably improves the efficacy of suppressing food intake and its duration to reduce body weight and body fat, thereby being useful for the treatment of obesity-related diseases.

Power converters having reduced body diode conduction loss, reduced reverse recovery loss and lower switching noise, among other benefits, have a resonant capacitor Cr connected across an unfiltered output. The resonant capacitor Cr resonates with the leakage inductance Lk of the transformer. The resonant capacitor and leakage inductance are selected such that ½ a LC resonance period is equal to an ON time of each secondary switch S1 S2. The resonance provides zero current switching for secondary switches S1 S2, eliminates zero body diode conduction during dead times, and eliminates reverse recovery losses in the secondary switches. The present invention is applicable to many different circuit topologies such as full bridge, active clamp forward, push-pull forward, and center-tap secondary. The present converters provide high energy conversion efficiency and high frequency operation.

Modified oxyntomodulin derivatives. Such derivatives can be used for the treatment of metabolic diseases such as diabetes and obesity.